GlassScriptPrepare for your visit
Joseph Daniel Mock
Hematology & Oncology · Blacksburg, VA · NPI 1194111005
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,931.90
in general payments reported to CMS, 2019-2025 · $1,879 in 2025
The $1,879 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- Novartis Pharmaceuticals Corporation $1,256.45
- Astellas Pharma US INC $468.71
- Pfizer INC. $343.66
- Genentech USA, INC. $307.52
- Incyte Corporation $250.29
- E.R. Squibb & Sons, L.L.C. $244.65
Drugs and devices associated with these payments
Jakafi Zejula Pluvicto Imbruvica Epkinly Keytruda Opdualag Lenvima Xtandi Brukinsa Tukysa Itovebi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Joseph Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/9714588/joseph-daniel-mock